WBI Investments’s Medifast MED Stock Holding History

WBI Investments’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-17,367	Closed	-$656K	–	352
2016 Q3	$656K	Buy	+17,367	New	+$623K	0.03%	232

Other funds holding MED

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WBI Investments's MED Position: Q4 2016 in Review

WBI Investments sold out of Medifast (MED) in Q4 2016, closing a stake of 17,367 shares — an estimated $656K sold.

WBI Investments first reported a position in MED in Q3 2016 and held it in 1 quarter. The position peaked at $656K in Q3 2016. 162 funds tracked by Wall St. Rank hold MED as of Q4 2016.

WBI Investments reported no remaining Medifast position as of Q4 2016 after selling out during the quarter.
WBI Investments sold 17,367 Medifast shares in Q4 2016, an estimated $656K.
WBI Investments first reported a position in Medifast in Q3 2016 and held it in 1 quarter.
WBI Investments's Medifast position peaked at $656K in Q3 2016.
162 funds tracked by Wall St. Rank held Medifast as of Q4 2016.

Based on WBI Investments's 13F filing for Q4 2016, filed 14 Feb 2017.